Making the announcement, she tweeted from an EU summit in Portugal saying; ‘Happy to announce that the EU Commission has just approved a contract for guaranteed 900 million doses (+900 million options) with BioNTech/Pfizer for 2021-2023,‘
‘Other contracts and other vaccine technologies will follow,’ she further promised.
Read Also: NAFDAC Approves Pfizer-BionTech Vaccine For Emergency Use
The contract, on top of the 600 million BioNTech/Pfizer doses the commission has already secured, aims to supply the bloc — population 450 million — with enough jabs for booster shots, the EU said.
They could also ‘expand vaccination to minors and for exports to lower-income countries outside the EU’, it added.
Von der Leyen has said that the mRNA technology used by BioNTech/Pfizer and other vaccine-makers has proven safe and effective.
BioNTech of Germany and Pfizer of the United States have stepped up supply Europe with their jointly produced doses, and their vaccine is currently the main one being used in the EU.
AFRICA DAILY NEWS, NEW YORK
